Lauren A. Daniel
@5am Venture Management, Llc
Latest period2024 - Q3ReportedManaged Assets$484.005MTotal holdings28
Assets growth rate8.26%Assets growth rate (2-Q avg)4.19%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in 5am Venture Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 28 positions.
Assets under management
The assets under management (AUM) of 5am Venture Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 484.005M in assets, with a quarterly growth rate of 8.26% and a 2-quarter average growth rate of 4.19%. The portfolio is managed by Lauren A. Daniel, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
TRDAEntrada Therapeutics Inc
| 14.56% | $70.446M 4.408M shares@ $15.99 avg price | |
ELVNEnliven Therapeutics Inc
| 9.25% | $44.751M 1.752M shares@ $25.55 avg price | Decreased -32.88% |
SKYESkye Bioscience Inc
| 8.01% | $38.76M 9.913M shares@ $3.92 avg price | Decreased -2.61% |
ARTVArtiva Biotherapeutics Inc
| 7.52% | $36.359M 2.353M shares@ $15.46 avg price | New Position |
DNTHDianthus Therapeutics Inc
| 6.97% | $33.722M 1.232M shares@ $27.38 avg price | Decreased -0.1% |
BHVNBiohaven Ltd
| 4.95% | $23.934M 478,972 shares@ $49.98 avg price | Increased 1.92% |
TYRATyra Biosciences Inc
| 4.57% | $22.083M 939,298 shares@ $23.52 avg price | |
CNTACentessa Pharmaceuticals Plc
| 4.25% | $20.547M 1.285M shares@ $15.99 avg price | Increased 3.22% |
TECXTectonic Therapeutic Inc
| 4.05% | $19.59M 646,524 shares@ $30.3 avg price | |
PRAXPraxis Precision Medicines I
| 4.05% | $19.564M 340,000 shares@ $57.54 avg price |